Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

CorticaLINK Spinal Fusion Platform

K-Number: K193465 · 2020-01-10

Decision Date2020-01-10
Product CodeNKB
Advisory CommitteeOR
DecisionSubstantially Equivalent

Device Summary

CorticaLINK Spinal Fusion Platform is a medical device manufactured by Spine Smith Holdings, LLC. It received FDA 510(k) clearance on 2020-01-10 under approval number K193465. The device is classified under product code NKB. It was reviewed by the OR advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the CorticaLINK Spinal Fusion Platform?

CorticaLINK Spinal Fusion Platform is a medical device that received FDA 510(k) clearance on 2020-01-10. It is manufactured by Spine Smith Holdings, LLC. The 510(k) number is K193465.

When was CorticaLINK Spinal Fusion Platform approved by the FDA?

CorticaLINK Spinal Fusion Platform received FDA 510(k) clearance on 2020-01-10, under approval number K193465.

What company makes CorticaLINK Spinal Fusion Platform?

CorticaLINK Spinal Fusion Platform is manufactured by Spine Smith Holdings, LLC.

What is the FDA product code for CorticaLINK Spinal Fusion Platform?

The FDA product code for CorticaLINK Spinal Fusion Platform is NKB.

Related Clinical Trials

Related PubMed Literature

Other Devices by Spine Smith Holdings, LLC

Related Devices (Code: NKB)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.